Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
Collaboration combines leading technologies to develop breakthrough, mRNA-enabled in vivo expressed TCER® molecules Comp…
Collaboration combines leading technologies to develop breakthrough, mRNA-enabled in vivo expressed TCER® molecules Comp…
Semodia, Pipe Predict and Lumatix Biotech - these are the winners of the ACHEMA Start-up Award. They convinced with thei…
eccenca is partnering with Tietoevry to accelerate the Dynamic Supply Chain with the help of a digital supply chain twin…
Automated weld seam tracking in robot welding cells is a complex task in a harsh industrial environment. The micrometer-…
INTT Inductive Sensors for Extreme Temperature Ranges detect metallic objects contactlessly at ambient temperatures of u…
ACTengine® patient recruitment remains on track; as of end of July, a total of 27 patients have been treated with IMA201…
Around 600 HARTING employees have been vaccinated with the BioNTech vaccine for the first time on Tuesday. The vaccinati…
Immatics’ second TCR Bispecifics program IMA402 demonstrates tumor cell killing in vitro and complete regressions of…
Top priority for the family-owned technology and solutions provider Bizerba is to secure the future. After modernizing i…
ubitricity is now the UK’s largest public EV charging network with over 2,554 charge points and a 12,5% market share. St…